new version V2017

pulmonary embolism
Description Results

     

  • Group by...

TrialStudied treatmentControl treatmentpatientsROBResultNCT

antithrombotics

Certoparin
Certoparin-Study Group sub group, 1998Certoparinunfractionated heparin Exploratory Negative
dalteparin
Kuijer, 1995Dalteparinunfractionated heparinNegative
Meyer, 1995Dalteparinunfractionated heparinNegative
enoxaparin
PREPIC, 1998Enoxaparinunfractionated heparin Risk of bias Negative
Merli sub group, 2001Enoxaparinunfractionated heparin Exploratory Negative
nadroparin
European multicentre study, 1991Nadroparinunfractionated heparin Risk of bias Negative
Prandoni sub-group, 1992Nadroparinunfractionated heparin Exploratory Negative
Thery, 1992Nadroparinunfractionated heparin Exploratory Negative
reviparin
COLOMBUS sub group, 1997Reviparinunfractionated heparin Exploratory Negative
tinzaparin
ACTSG (Hull) sub-group, 1992Tinzaparinunfractionated heparin Exploratory Negative
THESEE, 1997Tinzaparinunfractionated heparin Risk of bias Negative
Campbell, 1998Tinzaparinunfractionated heparinNegative

fibrinolysis

candesartan
Tebbe, 2009desmoteplasealteplase Exploratory -
rt-PA
PIOPED, 1990rt-PAplacebo Exploratory Negative
Levine, 1990rt-PAplacebo Low risk of bias Negative
PAIMS 2, 1992rt-PAno fibrinolysis Exploratory Negative
Goldhaber, 1993rt-PAno fibrinolysis Exploratory Negative
Konstantinides, 2002rt-PAplacebo Low risk of bias Negative
streptokinase
Tibbutt, 1974streptokinaseno fibrinolysis Exploratory Negative
Ly, 1978streptokinaseno fibrinolysis Exploratory Negative
Jerjes-Sanchez, 1995streptokinaseno fibrinolysis Exploratory -
tenecteplase
PEITHO ongoing tenecteplaseplacebo - NCT00639743
urokinase
UPET, 1973urokinaseplacebo Low risk of bias Negative
Marini, 1988urokinaseno fibrinolysis Exploratory -



- About - Browse pathology | treatment - Site map - Credits Made with in Lyon - Contact us - Privacy policy - Licence Creative Commons